1. A multicenter, open‐label, phase II study of tirabrutinib (ONO/GS‐4059) in patients with Waldenström's macroglobulinemia. Issue 9 (20th July 2020) Authors: Sekiguchi, Naohiro; Rai, Shinya; Munakata, Wataru; Suzuki, Kenshi; Handa, Hiroshi; Shibayama, Hirohiko; Endo, Tomoyuki; Terui, Yasuhito; Iwaki, Noriko; Fukuhara, Noriko; Tatetsu, Hiro; Iida, Shinsuke; Ishikawa, Takayuki; Shiibashi, Ryota; Izutsu, Koji Journal: Cancer science Issue: Volume 111:Issue 9(2020) Page Start: 3327 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A phase 2 study of polatuzumab vedotin + bendamustine + rituximab in relapsed/refractory diffuse large B‐cell lymphoma. Issue 7 (4th June 2021) Authors: Terui, Yasuhito; Rai, Shinya; Izutsu, Koji; Yamaguchi, Motoko; Takizawa, Jun; Kuroda, Junya; Ishikawa, Takayuki; Kato, Koji; Suehiro, Youko; Fukuhara, Noriko; Ohmine, Ken; Goto, Hideki; Yamamoto, Kazuhito; Kanemura, Nobuhiro; Ueda, Yasunori; Ishizawa, Kenichi; Kumagai, Kyoya; Kawasaki, Atsuko; Sa... Journal: Cancer science Issue: Volume 112:Issue 7(2021) Page Start: 2845 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Bearing 19q13 aberration predicts poor prognosis in non‐germinal centre type of CD5+DLBCL. (26th October 2017) Authors: Mishima, Yuko; Terui, Yasuhito; Yokoyama, Masahiro; Nishimura, Noriko; Ueda, Kyoko; Kusano, Yoshiharu; Yamauchi, Hirofumi; Inoue, Norihito; Takahashi, Anna; Tsuyama, Naoko; Mishima, Yuji; Takeuchi, Kengo; Hatake, Kiyohiko Journal: British journal of haematology Issue: Volume 183:Number 4(2018) Page Start: 661 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CTNI-66. ONE-YEAR FOLLOW-UP DATA OF PHASE I/II STUDY OF TIRABRUTINIB IN PATIENTS WITH RELAPSED OR REFRACTORY PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA. (9th November 2020) Authors: Mishima, Kazuhiko; Narita, Yoshitaka; Nagane, Motoo; Terui, Yasuhito; Arakawa, Yoshiki; Yonezawa, Hajime; Asai, Katsunori; Fukuhara, Noriko; Sugiyama, Kazuhiko; Shinojima, Naoki; Aoi, Arata; Nishikawa, Ryo Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii57 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Final results of a phase II study of nivolumab in Japanese patients with relapsed or refractory classical Hodgkin lymphoma. (8th August 2020) Authors: Maruyama, Dai; Terui, Yasuhito; Yamamoto, Kazuhito; Fukuhara, Noriko; Choi, Ilseung; Kuroda, Junya; Ando, Kiyoshi; Hattori, Akira; Tobinai, Kensei Journal: Japanese journal of clinical oncology Issue: Volume 50:Number 11(2020) Page Start: 1265 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Infusion Rate Escalation Study of Rituximab in Patients with CD20+ B-Cell Lymphomas: A Single Institution Analysis in Japan. (3rd April 2013) Authors: Yokoyama, Masahiro; Terui, Yasuhito; Takeuchi, Kengo; Nara, Eriko; Nakano, Kenji; Ueda, Kyoko; Nishimura, Noriko; Mishima, Yuko; Sakajiri, Sakura; Tsuyama, Naoko; Ozawa, Keiya; Hatake, Kiyohiko Other Names: Kildal W. Academic Editor.; Liu Y.-Y. Academic Editor. Journal: ISRN oncology Issue: Volume 2013(2013) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Lenalidomide and low‐dose dexamethasone in Japanese patients with newly diagnosed multiple myeloma: A phase II study. Issue 5 (30th March 2016) Authors: Suzuki, Kenshi; Shinagawa, Atsushi; Uchida, Toshiki; Taniwaki, Masafumi; Hirata, Hirokazu; Ishizawa, Kenichi; Matsue, Kosei; Ogawa, Yoshiaki; Shimizu, Takayuki; Otsuka, Maki; Matsumoto, Morio; Iida, Shinsuke; Terui, Yasuhito; Matsumura, Itaru; Ikeda, Takashi; Takezako, Naoki; Ogaki, Yumi; Midorik... Journal: Cancer science Issue: Volume 107:Issue 5(2016) Page Start: 653 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Long‐term outcomes and central nervous system relapse in extranodal natural killer/T‐cell lymphoma. Issue 4 (2nd March 2022) Authors: Miyazaki, Kana; Suzuki, Ritsuro; Oguchi, Masahiko; Taguchi, Senzo; Amaki, Jun; Maeda, Takeshi; Kubota, Nobuko; Maruyama, Dai; Terui, Yasuhito; Sekiguchi, Nodoka; Takizawa, Jun; Tsukamoto, Hiroyuki; Murayama, Tohru; Ando, Toshihiko; Matsuoka, Hiroshi; Hasegawa, Masatoshi; Wada, Hideho; Sakai, Rika... Journal: Hematological oncology Issue: Volume 40:Issue 4(2022) Page Start: 667 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. ML-05 One-year follow-up data of phase I/II study of tirabrutinib in patients with relapsed or refractory primary central nervous system lymphoma. (28th November 2020) Authors: Mishima, Kazuhiko; Narita, Yoshitaka; Nagane, Motoo; Terui, Yasuhito; Arakawa, Yoshiki; Yonezawa, Hajime; Asai, Katsunori; Fukuhara, Noriko; Sugiyama, Kazuhiko; Shinojima, Naoki; Aoi, Arata; Nishikawa, Ryo Journal: Neuro-oncology advances Issue: Volume 2(2020)Supplement 3 Page Start: ii16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Multicenter phase II study of nivolumab in Japanese patients with relapsed or refractory classical Hodgkin lymphoma. Issue 5 (19th May 2017) Authors: Maruyama, Dai; Hatake, Kiyohiko; Kinoshita, Tomohiro; Fukuhara, Noriko; Choi, Ilseung; Taniwaki, Masafumi; Ando, Kiyoshi; Terui, Yasuhito; Higuchi, Yusuke; Onishi, Yasushi; Abe, Yasunobu; Kobayashi, Tsutomu; Shirasugi, Yukari; Tobinai, Kensei Journal: Cancer science Issue: Volume 108:Issue 5(2017) Page Start: 1007 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗